Clinical Trial Details
| Trial ID: | L4808 |
| Source ID: | NCT02571608 |
| Associated Drug: | Metformin |
| Title: | Continuation of Metformin to Improve And Keep Peri-operative Glycemic Control |
| Acronym: | CANTAKE |
| Status: | WITHDRAWN |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes Mellitus Type 2 |
| Interventions: | DRUG: Metformin|DRUG: Placebo |
| Outcome Measures: | Primary: Recruitment rate, This will be documented as total number of individuals recruited and randomized in the study., One year | Secondary: Glycemic control, Mean CBG score difference between 2 groups, Baseline, Intra-op, 1, 6, 12, 24 and 48 hours post-op|Wound infection, Wound infection present at follow-up visit, At follow up visit with surgeon at approx. 6 weeks post-surgery|Length of Hospital Stay, Mean length of stay for all patients, One year |
| Sponsor/Collaborators: | Sponsor: McMaster University |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 0 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT |
| Start Date: | 2022-01-01 |
| Completion Date: | 2022-12-31 |
| Results First Posted: | |
| Last Update Posted: | 2021-10-08 |
| Locations: | |
| URL: | https://clinicaltrials.gov/show/NCT02571608 |
